WGS Analysis of COVID-19 Positive Patients

Completed

Conditions studied: Coronavirus Infection, COVID-19

In brief

We aim to better understand the mode of action of COVID-19 in the context of its interaction with the host genome through whole-genome sequencing.

Key facts

Study ID

NCT04353401

Run by

Vanda Pharmaceuticals

People needed

79

Starts

2020-08-03

Expected to finish

2022-03-09

Last updated by the study team

2024-03-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Ability and acceptance to provide written informed consent and fluent in English.
• Men or women between 18-100+ years, inclusive.
• Willing to comply with study procedures.
• SARS-CoV-2 positive test result as confirmed by a RT-PCR assay with a sputum or nasopharyngeal sample (either done prior to or at the screening visit).

Where it is running

• Vanda Investigational Site — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.